Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Garreau

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|December 5, 2025
Standard formulas and individualised parenteral nutrition preparations in very low birth weight infantsLaurie Dez, Stéphane Haÿs, Gilles Leboucher, et al.
Antimicrobial Agents and Chemotherapy|July 6, 2021
Model-Based Comparative Analysis of Rifampicin and Rifabutin Drug-Drug Interaction ProfileVianney Tuloup, Mathilde France, Romain Garreau, et al.
Clinical Pharmacokinetics|August 16, 2022
Daptomycin Physiology-Based Pharmacokinetic Modeling to Predict Drug Exposure and Pharmacodynamics in Skin and Bone TissuesRomain Garreau, Damien Montange, Antoine Grillon, et al.
Digital Health|March 22, 2024
What are the available online resources targeting psychosocial burden among stroke survivors and their informal caregivers: A scoping reviewMarion Delvallée, Romain Garreau, Anne Termoz, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2025
Risk factors of daptomycin overexposure: a case-control studyClotilde Vellat, Romain Garreau, Aurélien Millet, et al.
Open Forum Infectious Diseases|November 30, 2022
Seventeen Cases of Daptomycin-Induced Eosinophilic Pneumonia in a Cohort of Patients Treated for Bone and Joint Infections: Proposal for a New AlgorithmTruong-Thanh Pham, Romain Garreau, Fabien Craighero, et al.
The Journal of Antimicrobial Chemotherapy|February 7, 2024
Comparison of daptomycin and glycopeptide efficacy and safety for the treatment of Gram-positive infections: a systematic review and meta-analysisAbdelwahab Boulekbache, Fanny Maldonado, Raphael Kavafian, et al.
The Journal of Antimicrobial Chemotherapy|February 7, 2021
Population pharmacokinetics of daptomycin in patients with bone and joint infection: minimal effect of rifampicin co-administration and confirmation of a sex differenceRomain Garreau, Romain Bricca, Marie-Claude Gagnieu, et al.
Antibiotics (Basel, Switzerland)|October 23, 2021
Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill PatientRomain Garreau, Benoît Falquet, Lisa Mioux, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2024
Reply to Tannous et alRomain Garreau, Truong-Thanh Pham, Laurent Bourguignon, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|December 5, 2025
Standard formulas and individualised parenteral nutrition preparations in very low birth weight infantsLaurie Dez, Stéphane Haÿs, Gilles Leboucher, et al.
Antimicrobial Agents and Chemotherapy|July 6, 2021
Model-Based Comparative Analysis of Rifampicin and Rifabutin Drug-Drug Interaction ProfileVianney Tuloup, Mathilde France, Romain Garreau, et al.
Clinical Pharmacokinetics|August 16, 2022
Daptomycin Physiology-Based Pharmacokinetic Modeling to Predict Drug Exposure and Pharmacodynamics in Skin and Bone TissuesRomain Garreau, Damien Montange, Antoine Grillon, et al.
Digital Health|March 22, 2024
What are the available online resources targeting psychosocial burden among stroke survivors and their informal caregivers: A scoping reviewMarion Delvallée, Romain Garreau, Anne Termoz, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2025
Risk factors of daptomycin overexposure: a case-control studyClotilde Vellat, Romain Garreau, Aurélien Millet, et al.
Open Forum Infectious Diseases|November 30, 2022
Seventeen Cases of Daptomycin-Induced Eosinophilic Pneumonia in a Cohort of Patients Treated for Bone and Joint Infections: Proposal for a New AlgorithmTruong-Thanh Pham, Romain Garreau, Fabien Craighero, et al.
The Journal of Antimicrobial Chemotherapy|February 7, 2024
Comparison of daptomycin and glycopeptide efficacy and safety for the treatment of Gram-positive infections: a systematic review and meta-analysisAbdelwahab Boulekbache, Fanny Maldonado, Raphael Kavafian, et al.
The Journal of Antimicrobial Chemotherapy|February 7, 2021
Population pharmacokinetics of daptomycin in patients with bone and joint infection: minimal effect of rifampicin co-administration and confirmation of a sex differenceRomain Garreau, Romain Bricca, Marie-Claude Gagnieu, et al.
Antibiotics (Basel, Switzerland)|October 23, 2021
Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill PatientRomain Garreau, Benoît Falquet, Lisa Mioux, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2024
Reply to Tannous et alRomain Garreau, Truong-Thanh Pham, Laurent Bourguignon, et al.
Pageof 2